Is Nicotinamide Riboside Muscle Function Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Nicotinamide Riboside Muscle Function Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Aging is accompanied by a decline in physiological function and increased vulnerability to disease, with mitochondrial dysfunction and epigenetic alterations recognized as key hallmarks. [Heikkinen A (2026); evidence level 4] - NR supplementation was associated with reduced muscle EAA, particularly when measured with the PCHannum, MEAT, and DunedinPACE clocks, while HIIT produced opposite effects in some clocks, notably increasing pace of aging by DunedinPACE. [Heikkinen A (2026); evidence level 4] - Nicotinamide riboside (NR), a vitamin B3 precursor to NAD + , and high-intensity interval training (HIIT) have both been proposed to ameliorate aging-related mitochondrial decline, but their effects on skeletal muscle epigenetic aging are not fully elucidated. [Heikkinen A (2026); evidence level 4] - Sarcopenia is an age-related syndrome characterized by progressive loss of skeletal muscle mass and function, which is closely associated with impaired regenerative capacity of muscle satellite cells (MuSCs). [Li C (2026); evidence level 4] - We integrate evidence from nearly 60 representative preclinical and clinical studies, clarify the dual-function role of NAD+, and address current inconsistencies in the field. [Li C (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.